| 注册
首页|期刊导航|中国药业|医院门诊前置处方审核分析及改进

医院门诊前置处方审核分析及改进

孙坤 艾超

中国药业2017,Vol.26Issue(22):92-95,4.
中国药业2017,Vol.26Issue(22):92-95,4.DOI:10.3969/j.issn.1006-4931.2017.22.031

医院门诊前置处方审核分析及改进

Analysis and Improvement of Pre-Prescription Review in the Hospital Outpatient Service

孙坤 1艾超1

作者信息

  • 1. 清华大学附属北京清华长庚医院,北京 102218
  • 折叠

摘要

Abstract

Objective To improve the ability of prescription intervention and promote rational drug use in clinic. Methods According to Prescription Management Method and Management Regulation for Hospital Prescription Comments (trial),the records of 4584 pre-prescription review in the hospital outpatient service from July 2016 to June 2017 were classified and statistically analyzed,the perfor-mance reward and punishment mechanism,the improvement of education and training,and other aspects were analyzed. Results The un-reasonable prescriptions were mainly for incomplete clinical diagnosis (54. 28%),physician nonstandard signature (19. 74%),improper dosage (16. 19%),respectively,the irregular prescriptions accounted for 74. 02%. In addition,compared with before improvement,after the implementation of performance reward mechanism,the improvement of education and training,performance punishment,the intervention rate of irrational prescription increased by 145. 00%,46. 00% and 150. 00%,respectively. Conclusion The improvement of education and training according to the implementation of performance reward and punishment,and records of prescription intervention can improve the effect of prescription intervention in outpatient pharmacy. To reduce the irrational prescriptions in our hospital outpatient service,we should combine the pre-prescription examination and prescription review,constantly standardize the prescription behavior of physicians, and improve the prescription intervention ability of pharmacists.

关键词

前置处方审核/处方干预/门诊药房/合理用药/药房管理

Key words

pre-prescription review/prescription intervention/outpatient pharmacy/rational drug use/pharmacy management

分类

医药卫生

引用本文复制引用

孙坤,艾超..医院门诊前置处方审核分析及改进[J].中国药业,2017,26(22):92-95,4.

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文